Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $75 to $80.
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $75 to $80.